Knuefermann et al. showed that breast cancer cell lines co-expressing HER2 and HER3 had elevated AKT phosphorylation levels and were linked to enhanced resistance to several chemotherapeutic drugs[106]. This evidence concerns the gene ERBB2 and breast cancer.